Neal Fischbach

Bullous disorders associated with anti–PD-1 and anti–PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy

Jacob Siegel, Mariam Totonchy, William Damsky et al. · Journal of the American Academy of Dermatology · 2018 · 200 citations

Bullous Disorders, Lymphoid Neoplasia, Anti–pd-l1 Therapy +7

HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo

Neal Fischbach, Sofia Rozenfeld, Wei-Fang Shen et al. · Blood · 2004 · 135 citations · Full text

Molecular Phenotypes in Triple Negative Breast Cancer from African American Patients Suggest Targets for Therapy

Robert Lindner, Catherine Sullivan, Onyinye Offor et al. · PLoS ONE · 2013 · 86 citations · Full text

Breast Oncology, Molecular Phenotypes, Medicine +12

Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer

Julia Foldi, Andrea Silber, Emily Reisenbichler et al. · npj Breast Cancer · 2021 · 66 citations · Full text

Safety and Effectiveness of Bevacizumab-Containing Treatment for Non–Small-Cell Lung Cancer: Final Results of the ARIES Observational Cohort Study

Thomas J. Lynch, David R. Spigel, Julie R. Brahmer et al. · Journal of Thoracic Oncology · 2014 · 55 citations · Full text

Non–small-cell Lung Cancer, Oncology, Bevacizumab-containing Treatment +8